Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6935-6940, December 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, C. W.

Cleavage of Cellular and Extracellular Saccharomyces cerevisiae DNA by Bleomycin and Phleomycin1

Carol Wood Moore2

Department of Microbiology, Medical School, and Biochemistry and Biology Graduate Programs, City University of New York, New York, New York 10031

Low-molecular-weight phleomycin (Mr ~1500–1600) is considerably less active on a per mol basis than structurally related bleomycin in degrading purified Saccharomyces cerevisiae DNA. Phleomycin also exhibits a substantially higher requirement than bleomycin for ferrous ions. However, phleomycin (0.13 to 3.3 x 10-6 M) produced 7 to 350 times more breaks than bleomycin in prelabeled intracellular [2-14C]DNA and [6-3H]DNA and is considerably more cytotoxic than bleomycin. Phleomycin and bleomycin produced equivalent numbers of DNA breaks at equivalent, physiologically meaningful levels of survival, indicating that DNA breaks are related to lethal properties of the anticancer glycopeptides. Phleomycin degradation of extracellular DNA was only detectable at ≥1.7 x 10-4 M, approximately two orders of magnitude higher than the concentrations of phleomycin which yielded equivalent fragmentation of intracellular DNA, indicating that phleomycin causes substantially more degradation of intracellular DNA than extracellular DNA. In contrast, bleomycin (≥1.7 x 10-5 M) degradation of purified DNA is quite extensive and considerably greater than the degradation of DNA in cells incubated with the same or higher concentrations of bleomycin. Neither phleomycin nor bleomycin cleaved extracellular DNA in the absence of ferrous ions, although both chemical analogues cleaved intracellular DNA without adding iron. Therefore, the requirement for metal ion in stimulating DNA degradation by the two structural families of glycopeptidic antibiotics is met by the cell itself.

1 This study was supported by the NIH (Grant CA25609, Department of Health and Human Services); United Cancer Council, Inc. (Rochester, NY); American Cancer Society, Inc. (Grant IN18; New York, NY); Contract DEAC02-76EVO3490 with the United States Department of Energy at the University of Rochester, Department of Radiation Biology and Biophysics; The Aaron Diamond Foundation, New York, NY; and the City University of New York Medical School and City College.

2 Part of this study was conducted at the Department of Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642.

Received 1/30/89. Revised 5/12/89. Revised 8/23/89. Accepted 8/29/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.